117 related articles for article (PubMed ID: 7083222)
1. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
Houghton JA; Houghton PJ
Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
[TBL] [Abstract][Full Text] [Related]
2. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
Houghton JA; Tice AJ; Houghton PJ
Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
Houghton JA; Houghton PJ
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
[TBL] [Abstract][Full Text] [Related]
4. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
Kroener JF; Saleh F; Howell SB
Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
[TBL] [Abstract][Full Text] [Related]
5. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
6. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Loftin SK; Cheshire PJ; Morton CL; Houghton PJ; Dayan A; Jolivet J
Cancer Chemother Pharmacol; 1992; 30(6):423-32. PubMed ID: 1394798
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
[TBL] [Abstract][Full Text] [Related]
8. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
9. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
Campbell TN; Howell SB; Pfeifle C; House BA
Cancer Treat Rep; 1982 Sep; 66(9):1723-7. PubMed ID: 7116349
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of human tumor xenografts in genetically athymic mice.
Ovejera AA; Houchens DP; Barker AD
Ann Clin Lab Sci; 1978; 8(1):50-6. PubMed ID: 623430
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil (5-FU) and 5,10-methylene tetrahydrofolate (5,10-CH2FH4) as adjuvant therapy in an experimental rodent colon carcinoma model.
Carlsson G; Hafström LO; Spears CP; Gustavsson B; Larsson PA
Anticancer Res; 1997; 17(5A):3671-4. PubMed ID: 9413221
[TBL] [Abstract][Full Text] [Related]
15. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
[TBL] [Abstract][Full Text] [Related]
16. MTX-5-FU combination therapy compared to FUDR monotherapy in nude mice.
Zanea-Wangler E; Schmitz R; Kesseler J; Ploss HJ
Strahlenther Onkol; 1989 Jul; 165(7):544-6. PubMed ID: 2526380
[No Abstract] [Full Text] [Related]
17. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
[TBL] [Abstract][Full Text] [Related]
18. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.
Peters GJ; Van Dijk J; Nadal JC; Van Groeningen CJ; Lankelma J; Pinedo HM
In Vivo; 1987; 1(2):113-7. PubMed ID: 2979771
[TBL] [Abstract][Full Text] [Related]
19. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
20. Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice.
Rashidi B; An Z; Sun FX; Moossa AR; Hoffman RM
Clin Cancer Res; 2000 Jun; 6(6):2464-8. PubMed ID: 10873100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
